March 13, 2026 10:23 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'Nobody will hire them': Supreme Court says menstrual leave would backfire, hurt women's careers | Rupee sinks to record low as West Asia conflict shakes Indian markets | ₹20 lakh crore wiped out: Indian markets post worst week in 4 years amid West Asia tensions | America’s flip-flop on Russian oil: How Washington sends conflicting signals to India | Big diplomatic win! Iran allows Indian oil tankers through the Strait of Hormuz | ‘It was over in the first hour’: Trump declares victory in Iran war, says ‘nothing left to target’ | Indian-origin shopkeepers face targeted attacks in Wembley; Somali men suspected | Iran pulls out of 2026 FIFA World Cup amid war with US-Israel | Supreme Court allows first-ever passive euthanasia for 32-year-old man in coma for 13 years | As Iran-US war disrupts global gas supply, India issues guidelines to manage shortages
Delhi-Covaxin

No Covaxin doses for 18-44 years in Delhi from tomorrow

| @indiablooms | May 13, 2021, at 05:21 am

New Delhi/IBNS: People between the age group of 18-44 years will not get Covaxin doses in Delhi from Thursday as there is no stock of the Bharat Biotech developed vaccine left in the national capital.

The government has urged the central government to ensure uninterrupted supplies of vaccines, adding that Covishield stocks will last nine days.

There are four days of Covaxin left to be administered on frontline workers and those above 45.

The shots are essential for those who received the first dose around four weeks ago.

Earlier, Delhi Deputy Chief Minister Manish Sisodia has hit out at the Centre's vaccine management saying that Covaxin manufacturer Bharat Biotech has refused to supply the vaccine to the national capital.

Sisodia said Bharat Biotech has refused to supply the doses citing directives from the government and limited availability.

"Once again I would say exporting 6.6 crore doses was biggest mistake. We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply," he wrote.

Sisodia said Delhi has asked for the supply of 1.34 crore doses, equal doses of Bharat Biotech's Covaxin and Serum Institute of India’s Covishield, to vaccinate the 18-44 age group.

Delhi entered the fourth week of lockdown on Monday, with stricter restrictions this time including the shutdown of the metro.

The national capital reported 13,287 new coronavirus cases and 300 more fatalities on Wednesday, while the positivity rate came down to 17 per cent.

India is currently reeling under the second wave of COVID-19 infections with around 3.5 lakh cases and 4,000 deaths being reported daily.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.